Mild chronic stressors characteristically increase circadian trough corticosteroid concentrations in rats and man. The elevation in trough concentrations is often accompanied by a reduction in peak concentrations and no change in the daily mean values. Here we point out that elevation of trough glucocorticoids, probably through daily increases of glucocorticoid receptor occupancy, has major metabolic effects that bias organisms toward storage of calories as fat. Thus, chronic mild stress, by overriding the normal mineralocorticoid receptor-mediated corticosteroid feedback regulation of trough CRF and ACTH secretion, facilitates development of the metabolic syndrome.
Introduction
Tight regulation of ACTH is essential to control corticosteroid levels in blood because the adrenals, and corticosteroid synthesis and secretion, are slaves of ACTH and its hypothalamic drive. In turn, corticosteroids feedback at brain sites to inhibit subsequent drive to ACTH secretion. Autonomy of ACTH or cortisol secretion, as in Cushing's disease, results in well-recognized metabolic disorders including a syndrome that closely resembles the metabolic syndrome-X, or even non-insulin dependant diabetes mellitus. Clearly then, normal hypothalamic regulation of ACTH secretion is critical to normal homeostasis.
Understanding of the normal regulation of ACTH secretion by two receptors of differing af®nities for the natural corticosteroid ligands, cortisol and corticosterone (B), is essential to undertanding of the physical effects of chronic stress. Circadian regulation of hypothalamo ± pituitary ± adrenal (HPA) activity is mediated through activation by glucocorticoids of both the high af®nity mineralocorticoid receptor (MR) and the lower af®nity glucocorticoid receptor (GR) in the brain. In the body, the effects of corticosteroids are mediated only by activation of the GR. In the body, there are several mechanisms, such as high local concentrations of transcortin and the enzyme 11-b hydroxysteroid dehydrogenase, to prevent occupancy of MR by glucocorticoids. We propose that overriding MR feedback by stress, with consequent activation of GR throughout the day, results in more severe metabolic consequences than are currently appreciated. The results discussed were obtained primarily in rats, however, they appear to apply equally well to man. We ®rst review studies on the normal circadian regulation of HPA activity and its metabolic signi®cance; next we discuss the effects of chronic stress on HPA activity; and, ®nally, we delineate further the effects of what seem to be small, apparently innocuous increases in corticosteroids on metabolic processes.
Feedback regulation of ACTH secretion and signi®cance of the circadian trough in corticosteroids
Adrenalectomy results in massive hypersecretion of ACTH throughout the day and night, and replacement of corticosteroids restores the ACTH rhythm to normal, demonstrating that the well-known feedback effects of adrenal steroids are active throughout the 24 h day to maintain normal ACTH levels. 1, 2 Because the circulating concentrations of corticosteroids vary widely in a circadian pattern, they must therefore be regulated at very low levels as well as high levels. Figure 1 shows a normal circadian rhythm of corticosterone (B) in rats; levels vary from 0.1 mgadl during the trough of the rhythm to 20 mgadl during the peak, thus demanding a sensor that is accurate over a b200-fold range. Such a range exceeds the usual receptor binding range by a factor of 2. When it became clear that there are two corticosteroid receptors, the high af®nity MR and the lower af®nity GR, that bind corticosteroids in brain, 3,4 a solution to this regulatory problem emerged. Subsequent work has shown convincingly that, during the trough of the circadian rhythm, MR-occupancy maintains low, trough ACTH levels, whereas during the peak, and after stress, corticosteroid occupancy of both MR and GR is required to maintain ACTH concentrations at near normal values. 5 ± 10 Why should the trough, minimum corticosteroid levels, be regulated? Under nonstressful conditions, circulating corticosteroids are held at a minimum through activated MR. The corticosteroid levels during this time of day are so low that they essentially do not bind to the GR, 11 and thus, do not activate GRmediated processes. This allows only intermittent daily GR activation which is critically important for metabolic homeostasis.
The effects of arti®cially elevating trough B levels on MR-and GR-mediated effects were explored by Akana et al. 12 The HPA axis compensated for elevated trough B levels by reducing peak values, and at low doses of B the daily 24 h mean B remained the same (Figure 2 ). The functional signi®cance of the elevated trough values on both feedback (MR-and GR-mediated) and peripheral targets (GR-mediated) is shown in Figure 3 (left and right panels, respectively). Clearly, although the mean values of B over a 24 h period are the same under the three B-implant conditions, the ef®cacy of the B increases as trough levels rise.
Studies in rats have shown that under basal conditions, during the circadian trough, ACTH and corticosteroid secretion is constitutive. The hypothalamus does not secrete ACTH releasing factors at this time of day, as shown by the lack of effect on trough ACTH of hypothalamic lesions or immunoneutralization of these neuropeptides; by contrast, during the circadian peak, hypothalamic neuropeptide secretion is critical to elevate ACTH and B levels. 5 In man, the same control occurs, as shown by responses to subthreshold vasopressin injections in the morning and at night; vasopressin stimulates ACTH secretion in the morning, during peak circadian activity when hypothalamic secretion of corticotropin-releasing factor (CRF) occurs, but does not at night, during the circadian trough. 13 Distinct cortisol controls of trough vs peak ACTH secretion can also be inferred from the results of studies of patients with partial adrenal enzyme de®ciencies. In these individuals, ACTH or 17-hydroxyprogesterone levels are extremely high during the peak of the rhythm, but are normal during the trough, provided that some cortisol secretion (from 2 to 5 mgadl) occurs. Finally, administration of an MR antagonist elevates endogenous cortisol both during the trough and peak of the circadian rhythm in man, whereas administration of a GR antagonist only elevates ACTH and cortisol during the peak. 14, 15 Thus, there is the capacity, through association of corticosteroids with the two receptors of differing af®nities, to tightly regulate both trough and peak ACTH (and thus corticosteroid levels) in both rats and man. Functionally, the need for such regulation is clear from the biological responses in GR-target tissues to elevating trough, but not mean, corticosteroid levels.
Effects of chronic stress on circadian corticosteroid rhythms
Because the HPA axis responds to stress intensity, the magnitude of corticosteroid responses de®nes the is not a signi®cant increase in mean daily B levels in the diabetic rats, but that the normal period of inactivity, the circadian trough, does not occur, and that it is only at this time of day that B levels are elevated. Nonetheless, compared with controls, diabetic rats have lower thymus weight Ð a strictly GR-mediated effect. 44 Figure 2 Elevation of trough B by implantation of a subcutaneous pellet of B (mgBa100 mg pellet weight) into intact rats 5 days earlier causes a reduction in PM B levels such that mean B levels (average of six samples collected over 24 h) remain constant. Adapted from Akana et al.
severity of stress. Major, life-threatening stresses result in remarkable elevations in corticosteroid levels throughout the day, such that mean levels can achieve 10 times normal values. However, these levels of circulating corticosteroids frequently presage death. 16, 17 Moderate chronic stimuli, such as prolonged fasting or anorexia nervosa, tend to elevate circulating corticosteroid levels to about the circadian maximum throughout the day, resulting in mean levels that may be 4 ± 5 times normal. 18, 19 Again, these moderate stimuli provoke clearly abnormal metabolic responses and are treated as clinical emergencies. 20, 21 By contrast, chronic, mild stress may only slightly perturb the circadian corticosteroid rhythm and may not signi®cantly elevate daily mean levels. This effect of mild stress is seldom recognized as contributing to metabolic problems.
In rats subjected to the chronic mild stressors of streptozotocin-induced diabetes or chronic cold, there is only a subtle, but important, alteration in B rhythms ( Figure 1 ). Although peak B levels are usually normal, or even lower than normal, trough values are elevated above normal, into the range of GR occupancy. 22 There is no evidence for down-regulation in either MR or GR in brains of rats exposed to chronic, mild stress. 23, 24 Although the feedback effects of B on the hypothalamus and rest of brain provide a higher than normal signal to inhibit activity in the HPA axis, the chronic stress imposes a sustained hypothalamic drive, overriding the inhibitory effects of feedback, and facilitating subsequent responsivity of the HPA axis. 25, 26 Chronic mild stress with persistent elevation in B in rats results in relative intra-abdominal obesity. 27 This may also be true in man since the ratio of intra-abdominal to subcutaneous fat mass determined by MRI is greater than normal in both patients with Cushing's disease and anorexia nervosa. 28 In man, elevations in trough cortisol levels are characteristic of persistent, mild stress as well. Depression, mania, jet lag, aging, 29 ± 32 and a shortterm fast 33, 34 all result in increased trough cortisol levels with normal, or reduced peak values. The consequence of this elevation in trough values is to cause only slight, and frequently insigni®cant elevations of daily mean corticosteroid output. 32 However, the elevation in trough values appears to be suf®cient to raise corticosteroid levels into the range in which GR-activation can occur, and instead of intermittant GR-occupancy, chronic mild stress results in tonic GR occupancy.
Recent studies by Samuels and her co-workers 33, 34 have shown that a 52 h fast elevates trough cortisol levels and depresses TSH levels. To test whether the increase in trough cortisol levels in the absence of fasting could reduce TSH levels, volunteers were infused with a cortisol regimen that matched the cortisol produced during the second day of fasting. TSH levels were similarly reduced. Although there are several studies in rats showing that stress-induced elevations in the circadian trough corticosteroid levels exert metabolic effects, this is one of the few clinical reports that shows the same phenomenon. 
Effects of elevated corticosteroid levels on energy balance
We have tested the role of B on energy acquisition and deposition in adrenalectomized rats replaced with subcutaneous pellets of B that provide a clamped plasma B signal, either at low (below the daily mean), medium (normal daily mean) or high levels (double the daily mean). Because the major anabolic hormone, insulin, is extremely sensitive to B levels, we have compared the effects of B in control and diabetic rats. 35, 36 Figures 4 ± 6 show the effects of B on food intake and tryglycerides, insulin and insulinlike growth factor-1 (IGF-1), and body and white adipose tissue weights in such rats. It is important to note that there is a very strong interaction between B and insulin and many of the effects of B on the endpoints measured are affected by the B-dependent increase in insulin.
Increasing B stimulates food intake ( Figure 4 , left) and triglyceride levels (Figure 4 , right) in control and, to a much greater extent, diabetic rats. The effects of B on food intake are mirrored by increases in NPY mRNA expression 35 and decreases in CRF mRNA expression 37 in the hypothalamus, suggesting that Binduced changes in hypothalamic neuropeptides that are known to alter feeding behavior may be involved in the effects of B on food intake. The dose-related stimulation of circulating triglyceride levels by B probably re¯ects the complex effects of B on triglyceride synthesis, secretion and reuptake by liver, 38 and the remarkable increase of this effect in diabetic rats re¯ects the absence of insulin and its anabolic effects.
Increasing B markedly stimulates insulin concentrations, probably through its effects on hepatic gluconeogenesis ( Figure 5, left) . The increased insulin levels occur prior to any evidence for peripheral insulin insensitivity, and frequently glucose levels are signi®cantly decreased in the rats replaced with medium B levels. 36 The increased insulin levels would be expected to antagonize the stimulatory effect of B on food intake, 39 perhaps explaining the reduced food intake in controls compared to diabetic rats. Independently of insulin, B inhibits circulating levels of IGF-1 ( Figure 5, right) , mirroring the decreased muscle and bone metabolism that occurs as B levels increase. 40 Although increasing B, with or without diabetes, inhibits body weight gain (Figure 6 , left), together with increasing insulin concentrations, B stimulates perirenal white adipose tissue (WAT) gain (Figure 6 , right), thus resulting in redistribution of energy stores. In the absence of hyperinsulinemia, high B is markedly catabolic to fat. It is likely that B-induced inhibition of central neural outputs to premotor sympathetic neurons, is also in part responsible for the accrual of fat stores in the presence of elevated insulin. This central effect of B also inhibits the activity of brown adipose tissue which is driven by the sympathetic nervous system. 36, 41 The effects of B on hormones and metabolism are mediated by GR. Examination of Figure 7 shows that levels of insulin and mesenteric WAT weight only begin to increase in response to B as the steroid levels achieve values that clearly place them in the range of GR occupancy. To emphasize this point, the data are plotted as a function of the log of steady-state B in these adrenalectomized, B-replaced rats that were examined 15 days after surgery and B-implantation, and there is clearly no increase in either variable below the B value of 3 mgadl, the point at which GR-occupancy appears to become functionally meaningful.
In rats that are adrenalectomized, replaced with B and exposed for 5 days either to room temperature control conditions or to cold, the important interactions between B, insulin and fat depot weight can be observed (Figure 8 ). Although there are only slight effects of B on insulin (and fat depot weight) at room temperature, these interactions become important in the cold. In this case, we were unable to test the effects of no steroid replacement, since the rats died in the cold when B levels were`2.3 mgadl. However, at Figure 5 Effects of B and streptozotocin-induced diabetes on food intake and plasma triglyceride levels 5 days after treatment in adrenalectomized rats. B increases chow intake in a doserelated manner and increases triglycerides similarly. Lack of insulin ampli®es the effects of B on both chow intake and triglyceride levels (note log scale for triglycerides). Adapted from Strack et al.
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Figure 4 Effects of B and streptozotocin-induced diabetes on plasma insulin and IGF-1 levels 5 days after treatment in adrenalectomized rats. B stimulates insulin and inhibits IGF-1 in normal rats and reduces both in diabetic rats. Adapted from Strack et al 35 and Rodgers et al.
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Control of the circadian HPA trough MF Dallman et al low steroid values, suf®cient to occupy the MR but just barely the GR, perirenal fat depot weight was very low in rats in the cold. As GR occupancy and activation rose, both insulin and fat depot weight increased, a potentially life saving response in these challenged rats. As in other studies, high B levels, although they resulted in the highest insulin and fat depot weights, reduced body weight (not shown).
As a whole, all of our results show that when B enters the range of GR occupancy tonically, it exerts a characteristic constellation of metabolic effects which can be summarized as increased caloric acquisition and insulin secretion, storage of calories as fat and loss of body weight, presumably as a consequence of major catabolic effects of B on protein and Ca metabolism. The deposition of fat is accomplished only in the presence of both elevated B and insulin (compare results in diabetic rats with those in rats in the cold), and it is particularly true in fat stores of abdominal, rather than subcutaneous origin (unpublished). Metabolically the rats resemble people with a mild form of Cushing's disease or depression, even when only small elevations of trough levels of B occur. Generally this effect in stressed rats is not obvious unless looked for, since stress in rats uniformly reduces chow intake, and decreases overall insulin levels. 42 However, even in the cold, which reduces insulin, the cold-induced elevation in B results in higher insulin levels and perirenal fat depot weights than would otherwise be observed (Figure 8 ).
Conclusions (Figure 9)
If one accepts the strong evidence that the normal low MR-determined trough corticosteroid levels do not appreciably occupy GR, then GR are activated only during a part of each day. Maintenance of the normal, very low circadian trough levels of corticosteroids appears to be critical for the maintenance of normal metabolism. It is through GR activation that corticosteroids exert their effects on many neural processes (such as food intake and inhibition of sympathetic ouput) and target tissues in the body; thus, when trough corticosteroid levels are elevated into the GR-occupancy range by even mild chronic stress, the sequelae of abnormally elevated GR activation occur, even though mean corticosteroid levels may not be signi®cantly elevated. Food intake and insulin output are increased, body weight decreases, muscle wasting and fat (particularly abdominal fat) deposition occur.
Recent studies in man suggest that perceived chronic stress also¯attens the amplitude of the circadian cortisol rhythm by elevating trough and reducing peak levels; subjects who reported increased stress were abdominally obese, hyperinsulinemic and hypertensive. 43 Thus it appears that subtle disruption in regulation of trough glucocorticoid levels is injurious to health in both rats and man.
